Huvitz
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Huvitz makes ophthalmic medical devices, instruments used to test eyesight, diagnose eye conditions, and support eye surgery.
Its products serve three broad customer groups: opticians and optical shops, ophthalmology clinics, and surgical eye-care facilities. Listed on KOSDAQ, Korea's tech and small-cap board, the company covers the full range of ophthalmic equipment, from automated refraction testers and lens-edging machines used in optical shops to diagnostic and surgical instruments used in hospitals.
Summary is AI-generated and may contain errors · figures from DART filings
Huvitz in five facts
What does Huvitz do?
Huvitz makes ophthalmic medical devices, instruments used to test eyesight, diagnose eye conditions, and support eye surgery.
Where is Huvitz listed and in which sector?
Huvitz (Korean name: 휴비츠) trades under KRX code 065510 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Huvitz?
Its market capitalisation was US$55.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Huvitz's latest annual revenue and operating profit?
For fiscal year 2025, Huvitz reported revenue of US$89.1M, operating profit of US$4.2M and a net loss of US$3.7M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 0.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Share cancellation decisionOct 7
- DisclosureSep 28
- Treasury share acquisition via trust: status reportSep 8
- [Attachment amended] Material event report (merger)M&A · Aug 26
- Material event report (merger)
Huvitz Co., Ltd. resolved on August 24, 2026 to absorb-merge its wholly owned subsidiary Ossvis Co., Ltd. in a no-new-shares (non-capital-increase) small-scale merger, with a merger ratio of 1.0000000:0.0000000 and no change in Huvitz's largest shareholder, with a merger date of November 30, 2026.
M&A · Aug 24 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Huvitz updated its previously filed consolidated results for FY2025: revenue of US$80M (+0.1% year on year), operating profit of US$3.76M (−58.4% year on year) and a net loss of US$3.35M (from a profit a year earlier).
Earnings · Mar 12 · 2 versions - Cash/in-kind dividend decision
Huvitz declared a cash dividend of US$0.17 per share.
Dividend · Feb 24